Ethinyl estradiol was administered orally in a daily dose of 0.18-0.3mg for seven days to subjects with normal and abnormal thyroid function, and the changes of several parameters of the thyroid function during estrogen admin istration were investigated.
These results
show that ethinyl estradiol may have an effect at first on the metabolism of thyroxine-binding proteins.
The concentration and binding capacity of thyroxine-binding proteins may increase as a whole. The fact that T4 half-life is prolonged and free T, level stays as before in spite of the rise of PBI in estrogen administration might be due to suppressed decomposition of free T4.
These results are observed equally in subjects with intact and abnormal thy roid functions, and it is concluded that these phenomena have no relation to the pituitary-thyroid system.
Many investigators have demonstrated an increase in the capacity of thyroxine-binding globulin (TBG) and in the serum PBI level during pregnancy1-4 and by administration of estrogen. 5, 6 However, no marked clinical manifestations of hyperthyroidism were observed in these instances,1 and it was supposed that free thyroxine, the biologically active form of thyroxine in the blood, remained normal even in these situations.
In the present investigation, thyroxine-binding protein (TBP) was studied by the polyacrylamide gel electrophoresis and free thyroxine was determined by the method of Lee and Henry7 in subjects to whom large doses of estrogen (ethinvl estradiol) was administered.
A portion of the findings was presented elsewhere in abstract form.'
T. Sakurada et al. Ethinyl estradiol was administered orally in a daily dose of 0.18-0.3mg for seven days to 8 euthyroid subjects and to 9 hyperthyroid, 3 hypothyroid and 2 panhypopituitary patients.
MATERIALS AND METHODS
Serum PBI was measured by the method of Barker and Humphrey. 9 The maximum binding capacity of TBG was determined by the method of Tanaka and Starr.10 131I-T3 resin sponge uptake (Triosorb test) was measured by the method of Mitchel et al." Thyroidal 24-hour uptake of 131I, basal metabolic rate (BMR), thyroidal effective half-life of 131I (EHL) and thyroxine half-life in serum (T41/2) were determined. The free thyroxine index of Clark and Horn12 was calculated. where PBI is expressed in mpg per 100ml serum and the factor of 1.529 is used to convert the serum PBI into the thyroxine concentration.
The reagents for the polyacrylamide gel were prepared as follows.13 Radioactivity of the thin-layer polyacrylamide gel after electrophoresis was scanned by the thin-layer chromatogram scanner (Aloka, Japan), and the distribution of 131I-thyroxine among the serum thyroxine-binding proteins was estimated by planimetry. Protein-staining was then performed by placing the plate in 1% solution of amido black 10 B dye dissolved in a solution composed of 5:4:1 parts of water, methanol and glacial acetic acid, respectively. After about 2 hours, excess dye was removed by repeated washings with 10% acetic acid. This procedure gave a transparent background and dark blue protein bands. 
RESULTS

Free thyroxine and elutable fraction (EF)
Free thyroxine values of patients in various thyroid conditions are shown in Fig. 1 . There is a significant positive correlation of the values with free thyroxine index. The normal range of free thyroxine values was from 3.1 to 7.2mg per 100 ml serum. Free thyroxine was high in hyperthyroidism and low in hypothyroidism. Free thyroxine level also increased in subacute thyroiditis, reflecting outflow of the thyroid hormone into the blood. A negative correlation was observed between the free thyroxine level and binding capacity of TBG (Fig. 2) .
There was a positive correlation between the free thyroxine level and EF (Fig.  3) . EF was high in hyperthyroidism and low in hypothyroidism and in pregnancy. Decline of EF in pregnancy is remarkable. It may be due to the increased binding capacity of TBG.
Polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis showed that 131I-thyroxine added to serum combined with TBPA, albumin and TBG (Fig. 4) (Fig. 7) . The mean concentration of TBPA in normal subjects was about 38mg per 100ml serum, it was rather low in hyperthyroidism and high in hypothyroidism. The correlation between free thyroxine value and TBPA concentration was a negative one (Fig. 8) . The binding capacity of TBPA elevated in accordance with the increase in the concentration of TBPA (Fig. 9) , and it seems possible that the quantitative change of TBPA affects the binding capacity of TBPA. Effects of estrogen on the thyroid function Estrogen administered to euthyroid subjects brought about an increase of serum PBI level (Table 2) , without eliciting the symptoms of hyperthyroidism such as palpitation, tachycardia, tremor, sweating and remarkable rise in basal metabolic rate. Even in hypo-and hyperthyroid patients, no signs of remission or exacerbation were observed as a result of estrogen administration.
Estrogen administration caused no change in thyroidal 24-hour uptake of 1311, basal metabolic rate (BMR) and thyroidal effective half-life of 1111, but caused (Table 2) . EF decreased to a value of the hypothyroid state in 2out of 8 euthyroid subjects, and to one of euthyroid state in 7 out of 9 hyperthyroid patients (Table 2) . Triosorb test value also demonstrated the same tendency (Table 2) . No change in the free thyroxine value (Tf) was observed ( Table 2) . The changes were similar to those observed in pregnant women, in whom EF was low, serum PBI was high and free T. Sakurada et at. Figs. 11-12. Euthyroidism (before and after estrogen administration). of al. Figs. 15-16. Primary hypothyroidism (before and after estrogen administration). et at. Figs. 17-18. Hypopituitarism (before and after estrogen administration) . 1-2. Euthyroidism (before and after estrogen administration). 3-4. Hyperthyroidism (before and after estrogen administration). 5-6. Hypothyroidism (before and after estrogen administration). 7-8. Hypopituitarism (before and after estrogen administration).
thyroxine value was normal (Fig. 10) . Alteration in the distribution of added 131I-thyroxine among the serum thyroxine-binding proteins during administration of large doses of estrogen are shown in Figs. 11-18 . The ratio of 131I-thyroxine bound to TBPA decreased, whereas the ratio associated with TBG increased.
Estrogen administration brought about a fall of TBPA binding capacity and a rise of the TBG binding capacity (Fig. 19) The mean concentration of TBPA in euthyroid subjects was found to be 37mg per 100ml serum, somewhat higher than the value reported by Oppenheimer et al. 23 It is known that there are two bands (PA-1 and PA-2) which have a faster mobility than albumin on starch gel electrophoresis. TBPA is considered to reside in the PA-1.25-27 The concentration of TBPA on polyacrylamide gel electrophoresis may be slightly higher than that on starch gel electrophoresis because it contains both PA-1 and PA-2 fractions. Anyway, a positive correla tion was observed between TBPA concentration and the binding capacity of TBPA.
Oppenheimer et al.24 also found a linear correlation between the two quantities, when they studied the effects of serum dilution.
Effects of estrogen on the thyroid function
Administration of estrogen to subjects with various thyroid functions caused no significant changes in the free thyroxine level, basal metabolic rate, 24-hour uptake of 131I and effective half-life of 1311 Estrogen has been shown to increase serum PBI. 5.6 This finding was confirmed in the course of the present study.
In general, the increase in serum PBI means either accelerated thyroxine output from the thyroid gland or a decreased rate of peripheral thyroxine decomposi tion, or both.
So it is likely that this influence of estrogen is due to its stimulatory effect on the pituitary-thyroid system. These observations show that a functioning thyroid gland is not responsible for these estrogen induced changes. Thus the probability of direct effect of estrogen on the pituitary-thyroid system could be ruled out.
Serum thyroxine half-life was found to be prolonged. This may indicate a decrease of peripheral thyroxine turnover and/or an increase of thyroxine pool resulting from the enhanced capacity of thyroxine-binding protein. However, the latter possibility can be excluded, because no alterations were observed in the free thyroxine value, effective half-life of 1311 and thyroidal 24-hour uptake of 131I Effect of estrogen on TBPA It has been believed that estrogen has no influence on the binding capacity of TBPA.30 It was confirmed in the present study that TBPA concentration diminished significantly following estrogen administration. Recently, Reuter and Kennes31 reported on the effect of castration and of testosterone administra tion of the prealbumin concentration in the mouse serum. They reported that PA-1, separated by starch gel electrophoresis, was no longer detectable after castration and reappeared after testosterone injection. There is still an interesting result obtained in the present experiments. The binding capacity of both TBPA and TBG decreases in the hyperthyroid patients, but it increases in the hypothyroid patients.
In hyperthyroid patients, the reduction of the maximum thyroxine-binding capacity of TBPA is related to the decline of TBPA concentration in the serum.
From the fact that there is a linear correlation between TBPA concentration and the binding capacity of TBPA, there may exist a similar correlation between the concentration and the binding capacity of TBG. So the concentration of TBG is supposed to decrease in hyper thyroidism and to increase in hypothyroidism.
Though the binding capacities of TBPA and TBG decrease in hyperthyroidism, the serum PBI value, in fact , becomes higher. The possible explanation is that TBG and TBPA are already saturated with a high amount of endogenous thyroxine and there is little room for exogenous thyroxine to bind to serum proteins.
This problem of concentration and the binding capacity of thyroxine.-binding proteins in hyper-and hypothyroidism awaits further experiments.
